Cintia Piccina is Chief Commercial Officer of AlloVir, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Adaptimmune Therapeutics PLC
18 Jun 24
4
Adaptimmune Therapeutics PLC
18 Mar 24
4
Allovir, Inc.
5 Jul 23
3
Allovir, Inc.
21 Jun 23
4
Adaptimmune Therapeutics PLC
31 Jan 23
4
Adaptimmune Therapeutics PLC
17 Jan 23
4
Adaptimmune Therapeutics PLC
1 Aug 22
4
Adaptimmune Therapeutics PLC
31 Jan 22
3
Adaptimmune Therapeutics PLC
31 Jan 22
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Jun 24 | ADAP Adaptimmune Therapeutics | American Depositary Shares representing Ordinary Shares | Sell | Dispose S | No | No | 0.93 | 24,531 | 22.81 k | 38,293 |
| 18 Mar 24 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.0013 | 1,130,832 | 1.47 k | 1,130,832 |
| 18 Mar 24 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.25 | 5,088,864 | 1.27 mm | 5,088,864 |